Wall Street Analysts Predict a 143.41% Upside in Nurix Therapeutics (NRIX): Here's What You Should Know

Shares of Nurix Therapeutics, Inc. (NRIX) have gained 2.3% over the past four weeks to close the last trading session at $12.44, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $30.28 indicates a potential upside of 143.4%.The average comprises 18 short-term price targets ranging from a low of $16.00 to a high of $41.00, with a standard deviation of $6.49. While the lowest estim ...